HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 26.72
Day range
kr 26.36 - kr 30.18
Year range
kr 19.58 - kr 57.30
Market cap
2.01B SEK
Avg Volume
168.27K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 66.35M | 18.52% |
Operating expense | 139.24M | -29.40% |
Net income | -37.08M | 83.04% |
Net profit margin | -55.88 | 85.69% |
Earnings per share | -0.55 | 86.75% |
EBITDA | -92.78M | 41.53% |
Effective tax rate | -0.92% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 250.20M | -53.79% |
Total assets | 705.25M | -15.09% |
Total liabilities | 1.33B | 10.31% |
Total equity | -623.74M | — |
Shares outstanding | 67.81M | — |
Price to book | -2.90 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -37.08M | 83.04% |
Cash from operations | -151.87M | 19.70% |
Cash from investing | -628.00K | -441.38% |
Cash from financing | -1.30M | 29.96% |
Net change in cash | -155.08M | 18.63% |
Free cash flow | -115.07M | 37.34% |
About
Founded
2007
Website
Employees
138
